Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by aldo451on Apr 16, 2020 3:19pm
74 Views
Post# 30918204

RE:And this is why they want your shares:

RE:And this is why they want your shares:Are you retarded...nobody wants your shares! No really, how much do they pay for posting the same shyt day after day! aliases

They are not keeping their word. Before the rights offering, they said that the BLA would be filed before the end of 2019. Shortly after the $38M was raised, the filing date moved to H1 2020.
 
Partnership for Ryplazim was "expected" in 2019. Pritchard even stated this during his presentation at Piper Jaffray on December 4th!  I’m now thinking that the “unusual market activity” of Dec 24th was in anticipation of an “almost” done deal that didn’t happen. We are now 3.5 months into 2020 and still nothing!
 
While on this topic, can someone explain how a partnership for Ryplazim with upfront money could materialize without an approved product, even worse, without a BLA filing, A letter of intent?
 
I just don’t know what to make of this, nothing seems to add-up! I’ll give them a few more months, after which I will move on as this is taking its toll on me, not to mention all the lost opportunities while I wait and wait.
 
My level of frustration is beyond words.
<< Previous
Bullboard Posts
Next >>